Flora Growth (FLGC) Competitors $0.60 +0.01 (+2.21%) Closing price 03:58 PM EasternExtended Trading$0.57 -0.03 (-4.17%) As of 06:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FLGC vs. AADI, APLT, BLUE, COEP, DYAI, STTK, ELYM, ATNM, HOWL, and LVTXShould you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include Aadi Bioscience (AADI), Applied Therapeutics (APLT), bluebird bio (BLUE), Coeptis Therapeutics (COEP), Dyadic International (DYAI), Shattuck Labs (STTK), Eliem Therapeutics (ELYM), Actinium Pharmaceuticals (ATNM), Werewolf Therapeutics (HOWL), and LAVA Therapeutics (LVTX). These companies are all part of the "pharmaceutical products" industry. Flora Growth vs. Aadi Bioscience Applied Therapeutics bluebird bio Coeptis Therapeutics Dyadic International Shattuck Labs Eliem Therapeutics Actinium Pharmaceuticals Werewolf Therapeutics LAVA Therapeutics Aadi Bioscience (NASDAQ:AADI) and Flora Growth (NASDAQ:FLGC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment. Which has better earnings & valuation, AADI or FLGC? Flora Growth has higher revenue and earnings than Aadi Bioscience. Aadi Bioscience is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAadi Bioscience$25.07M1.46-$65.76M-$2.35-0.63Flora Growth$59.51M0.20-$57.04M-$1.32-0.45 Does the MarketBeat Community believe in AADI or FLGC? Flora Growth received 4 more outperform votes than Aadi Bioscience when rated by MarketBeat users. Likewise, 60.00% of users gave Flora Growth an outperform vote while only 39.29% of users gave Aadi Bioscience an outperform vote. CompanyUnderperformOutperformAadi BioscienceOutperform Votes1139.29% Underperform Votes1760.71% Flora GrowthOutperform Votes1560.00% Underperform Votes1040.00% Do institutionals and insiders believe in AADI or FLGC? 52.1% of Aadi Bioscience shares are held by institutional investors. Comparatively, 36.0% of Flora Growth shares are held by institutional investors. 37.3% of Aadi Bioscience shares are held by insiders. Comparatively, 13.0% of Flora Growth shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is AADI or FLGC more profitable? Flora Growth has a net margin of -30.99% compared to Aadi Bioscience's net margin of -246.06%. Aadi Bioscience's return on equity of -71.87% beat Flora Growth's return on equity.Company Net Margins Return on Equity Return on Assets Aadi Bioscience-246.06% -71.87% -57.28% Flora Growth -30.99%-268.17%-57.51% Does the media prefer AADI or FLGC? In the previous week, Flora Growth had 2 more articles in the media than Aadi Bioscience. MarketBeat recorded 2 mentions for Flora Growth and 0 mentions for Aadi Bioscience. Flora Growth's average media sentiment score of 1.45 beat Aadi Bioscience's score of 0.00 indicating that Flora Growth is being referred to more favorably in the news media. Company Overall Sentiment Aadi Bioscience Neutral Flora Growth Positive Do analysts rate AADI or FLGC? Aadi Bioscience presently has a consensus target price of $1.67, indicating a potential upside of 12.61%. Flora Growth has a consensus target price of $5.00, indicating a potential upside of 733.33%. Given Flora Growth's stronger consensus rating and higher probable upside, analysts plainly believe Flora Growth is more favorable than Aadi Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aadi Bioscience 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Flora Growth 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has more risk and volatility, AADI or FLGC? Aadi Bioscience has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, Flora Growth has a beta of 2.01, indicating that its stock price is 101% more volatile than the S&P 500. SummaryFlora Growth beats Aadi Bioscience on 13 of the 18 factors compared between the two stocks. Get Flora Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLGC vs. The Competition Export to ExcelMetricFlora GrowthPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.66M$6.69B$5.47B$7.92BDividend YieldN/A3.05%5.11%4.22%P/E Ratio-0.457.3222.5118.54Price / Sales0.20241.49397.62103.35Price / CashN/A65.8538.1834.62Price / Book0.776.486.734.25Net Income-$57.04M$143.41M$3.22B$248.18M7 Day Performance3.45%2.30%1.58%1.25%1 Month Performance0.02%7.14%4.05%3.76%1 Year Performance-64.91%-2.61%15.75%5.28% Flora Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLGCFlora Growth3.3206 of 5 stars$0.60+2.2%$5.00+733.3%-65.3%$11.66M$59.51M-0.45280Short Interest ↓Positive NewsGap UpAADIAadi BioscienceN/A$1.57+1.9%$1.67+6.2%-22.9%$38.77M$25.07M-0.6940Upcoming EarningsAPLTApplied Therapeutics4.0816 of 5 stars$0.33-0.1%$6.10+1,734.0%-90.7%$38.70M$455,000.00-0.2130Upcoming EarningsNews CoveragePositive NewsBLUEbluebird bio3.0043 of 5 stars$3.90-5.8%$44.60+1,043.6%-77.0%$38.18M$83.81M-0.10520Upcoming EarningsAnalyst ForecastCOEPCoeptis Therapeutics1.1128 of 5 stars$11.19+11.9%N/A+34.9%$37.65MN/A-1.932Short Interest ↓Gap UpDYAIDyadic International2.8942 of 5 stars$1.25+1.6%$6.00+380.0%-14.7%$37.61M$3.50M-5.437Short Interest ↓News CoverageSTTKShattuck Labs2.5582 of 5 stars$0.79+1.5%$7.50+855.3%-90.6%$37.61M$5.72M-0.51100Earnings ReportNews CoveragePositive NewsELYMEliem TherapeuticsN/A$1.26flatN/A-82.1%$37.49MN/A-2.389Gap DownATNMActinium Pharmaceuticals1.4132 of 5 stars$1.20-0.8%$7.40+516.7%-80.3%$37.44M$81,000.00-0.8630Analyst ForecastAnalyst RevisionHOWLWerewolf Therapeutics2.2545 of 5 stars$0.83-9.7%$9.00+984.6%-85.5%$37.20M$1.89M-0.5440Upcoming EarningsNews CoverageLVTXLAVA Therapeutics2.3476 of 5 stars$1.40+6.6%$3.17+126.7%-56.7%$36.75M$11.98M-1.3660Short Interest ↓ Related Companies and Tools Related Companies AADI Competitors APLT Competitors BLUE Competitors COEP Competitors DYAI Competitors STTK Competitors ELYM Competitors ATNM Competitors HOWL Competitors LVTX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLGC) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flora Growth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Flora Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.